Alleviating effects and mechanisms of action of large-leaf yellow tea drinking on diabetes and diabetic nephropathy in mice

[1]  Ruiyue Yang,et al.  Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice , 2020, Frontiers in Microbiology.

[2]  Chung S. Yang,et al.  Tea Drinking Alleviates Diabetic Symptoms via Upregulating Renal Water Reabsorption Proteins and Downregulating Renal Gluconeogenic Enzymes in db/db Mice. , 2020, Molecular nutrition & food research.

[3]  H. Herrema,et al.  Intestinal microbial metabolites in human metabolism and type 2 diabetes , 2020, Diabetologia.

[4]  F. Ren,et al.  Age- and diet-specific effects of chronic exposure to chlorpyrifos on hormones, inflammation and gut microbiota in rats. , 2019, Pesticide biochemistry and physiology.

[5]  H. Qin,et al.  Probiotics improve gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet. , 2019, Nutrition.

[6]  Fitra Rianto,et al.  Role of PKC and AMPK in hypertonicity-stimulated water reabsorption in rat inner medullary collecting ducts. , 2019, American journal of physiology. Renal physiology.

[7]  Shuangjiang Liu,et al.  Parabacteroides distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of Succinate and Secondary Bile Acids. , 2019, Cell reports.

[8]  X. Yao,et al.  Modulation of the Gut Microbiota in Rats by Hugan Qingzhi Tablets during the Treatment of High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease , 2018, Oxidative medicine and cellular longevity.

[9]  R. Reiter,et al.  Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high‐fat diet‐fed mice , 2018, Journal of pineal research.

[10]  Chi-Tang Ho,et al.  Roasting improves the hypoglycemic effects of a large-leaf yellow tea infusion by enhancing the levels of epimerized catechins that inhibit α-glucosidase. , 2018, Food & function.

[11]  I. Park,et al.  Effect of Kombucha on gut-microbiota in mouse having non-alcoholic fatty liver disease , 2018, Food Science and Biotechnology.

[12]  V. Tremaroli,et al.  Differential metabolic effects of oral butyrate treatment in lean versus metabolic syndrome subjects , 2018, Clinical and Translational Gastroenterology.

[13]  M. Murphy,et al.  Ketogenic diet enhances neurovascular function with altered gut microbiome in young healthy mice , 2018, Scientific Reports.

[14]  T. Igumenova,et al.  Structural Basis of Protein Kinase Cα Regulation by the C-Terminal Tail. , 2018, Biophysical journal.

[15]  Zhongwen Xie,et al.  Large Yellow Tea Attenuates Macrophage-Related Chronic Inflammation and Metabolic Syndrome in High-Fat Diet Treated Mice. , 2018, Journal of agricultural and food chemistry.

[16]  N. Vaziri,et al.  Altered microbiome in chronic kidney disease: systemic effects of gut-derived uremic toxins. , 2018, Clinical science.

[17]  S. Uchida,et al.  Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus , 2018, Clinical and Experimental Nephrology.

[18]  Baoxue Yang,et al.  Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice , 2018, Cellular Physiology and Biochemistry.

[19]  T. Ando,et al.  Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment. , 2018, Diabetes research and clinical practice.

[20]  Ji-Hoon Lee,et al.  Genes and Gut Bacteria Involved in Luminal Butyrate Reduction Caused by Diet and Loperamide , 2017, Genes.

[21]  Thanka Johnson,et al.  Impact of EGCG Supplementation on the Progression of Diabetic Nephropathy in Rats: An Insight into Fibrosis and Apoptosis. , 2017, Journal of agricultural and food chemistry.

[22]  X. Wan,et al.  Corrigendum: Safety and anti-hyperglycemic efficacy of various tea types in mice , 2016, Scientific Reports.

[23]  J. Holst,et al.  Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. , 2016, Clinical science.

[24]  Li Li Guo,et al.  Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice , 2016, Oxidative medicine and cellular longevity.

[25]  J. B. Lopes de Faria,et al.  The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial , 2016, Scientific Reports.

[26]  F. Bäckhed,et al.  From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites , 2016, Cell.

[27]  K. Burns,et al.  PGE2 receptor EP3 inhibits water reabsorption and contributes to polyuria and kidney injury in a streptozotocin-induced mouse model of diabetes , 2016, Diabetologia.

[28]  Yijun Wang,et al.  Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. , 2016, Molecular nutrition & food research.

[29]  E. Ferrannini,et al.  Energy Balance After Sodium–Glucose Cotransporter 2 Inhibition , 2015, Diabetes Care.

[30]  W. D. de Vos,et al.  Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. , 2015, Clinical nutrition.

[31]  M. Wheeler,et al.  FFAR out new targets for diabetes. , 2015, Cell metabolism.

[32]  Stefan Offermanns,et al.  Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes , 2015, Nature Medicine.

[33]  Jimmy D Bell,et al.  Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults , 2014, Gut.

[34]  Barbara M. Bakker,et al.  Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[35]  C. Lelliott,et al.  Adaptive Changes of the Insig1/SREBP1/SCD1 Set Point Help Adipose Tissue to Cope With Increased Storage Demands of Obesity , 2013, Diabetes.

[36]  Chung S. Yang,et al.  Prevention of chronic diseases by tea: possible mechanisms and human relevance. , 2013, Annual review of nutrition.

[37]  T. Ulven.  Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets , 2012, Front. Endocrin..

[38]  J. Sands,et al.  Lack of protein kinase C-α leads to impaired urine concentrating ability and decreased aquaporin-2 in angiotensin II-induced hypertension. , 2012, American journal of physiology. Renal physiology.

[39]  S. Bagnasco.  Protein kinase C-α comes to the rescue of aquaporin-2. , 2012, American journal of physiology. Renal physiology.

[40]  Jun Sheng,et al.  Inhibition of advanced glycation end product formation by Pu-erh tea ameliorates progression of experimental diabetic nephropathy. , 2012, Journal of agricultural and food chemistry.

[41]  A. M. Habib,et al.  Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2 , 2012, Diabetes.

[42]  Hong Zhao,et al.  PKCα regulates vasopressin-induced aquaporin-2 trafficking in mouse kidney collecting duct cells in vitro via altering microtubule assembly , 2012, Acta Pharmacologica Sinica.

[43]  A. Mitrakou.  Kidney: its impact on glucose homeostasis and hormonal regulation. , 2011, Diabetes research and clinical practice.

[44]  R. Fenton,et al.  Vasopressin-independent targeting of aquaporin-2 by selective E-prostanoid receptor agonists alleviates nephrogenic diabetes insipidus , 2011, Proceedings of the National Academy of Sciences.

[45]  E. Chao.  A paradigm shift in diabetes therapy--dapagliflozin and other SGLT2 inhibitors. , 2011, Discovery medicine.

[46]  R. Henry,et al.  SGLT2 inhibition — a novel strategy for diabetes treatment , 2010, Nature Reviews Drug Discovery.

[47]  A. Schwiertz,et al.  Microbiota and SCFA in Lean and Overweight Healthy Subjects , 2010, Obesity.

[48]  O. Marsenic.  Glucose control by the kidney: an emerging target in diabetes. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[49]  G. Tamma,et al.  Regulation of aquaporin-2 trafficking. , 2009, Handbook of experimental pharmacology.

[50]  Enrique Morales,et al.  Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes , 2008, Diabetes Care.

[51]  Leigh A. Stoddart,et al.  International Union of Pharmacology. LXXI. Free Fatty Acid Receptors FFA1, -2, and -3: Pharmacology and Pathophysiological Functions , 2008, Pharmacological Reviews.

[52]  S. Abdeen,et al.  Effect of green tea on kidney tubules of diabetic rats , 2008, British Journal of Nutrition.

[53]  Shinong Wang,et al.  Osmotic polyuria: an overlooked mechanism in diabetic nephropathy. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[54]  G. King,et al.  The role of protein kinase C activation in diabetic nephropathy. , 2007, Kidney international. Supplement.

[55]  G. King,et al.  Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice , 2006, Diabetes.

[56]  M. Delorenzi,et al.  Transcript Profiling Suggests That Differential Metabolic Adaptation of Mice to a High Fat Diet Is Associated with Changes in Liver to Muscle Lipid Fluxes* , 2004, Journal of Biological Chemistry.

[57]  H. Haller,et al.  Diminished loss of proteoglycans and lack of albuminuria in protein kinase C-alpha-deficient diabetic mice. , 2004, Diabetes.

[58]  V. Vallon,et al.  Evidence for a role of protein kinase C-alpha in urine concentration. , 2004, American journal of physiology. Renal physiology.

[59]  B. W. van Balkom,et al.  Glycosylation Is Important for Cell Surface Expression of the Water Channel Aquaporin-2 but Is Not Essential for Tetramerization in the Endoplasmic Reticulum* , 2004, Journal of Biological Chemistry.

[60]  K. Tuttle,et al.  A novel potential therapy for diabetic nephropathy and vascular complications: protein kinase C beta inhibition. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  M. Krempf,et al.  Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes. , 2003, The Proceedings of the Nutrition Society.

[62]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[63]  M. Stumvoll,et al.  Renal gluconeogenesis: its importance in human glucose homeostasis. , 2001, Diabetes care.

[64]  R. DeFronzo.  Pharmacologic Therapy for Type 2 Diabetes Mellitus , 1999, Annals of Internal Medicine.

[65]  Lawrence A Leiter,et al.  Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans. , 1997, Metabolism: clinical and experimental.

[66]  G. King,et al.  Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. , 1997, The Journal of clinical investigation.

[67]  M. Stumvoll,et al.  Renal glucose production and utilization: new aspects in humans , 1997, Diabetologia.

[68]  G. Mithieux,et al.  Glucose-6-Phosphatase mRNA and Activity Are Increased to the Same Extent in Kidney and Liver of Diabetic Rats , 1996, Diabetes.

[69]  R. Klein.  Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.

[70]  S. Teutsch,et al.  The problem of diabetic renal failure in the United States: an overview. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[71]  P. Fournel,et al.  Renal enzymes during experimental diabetes mellitus in the rat. Role of insulin, carbohydrate metabolism, and ketoacidosis. , 1984, Canadian journal of physiology and pharmacology.

[72]  G. W. Sanderson,et al.  The biochemistry and technology of tea manufacture. , 1980, Critical reviews in food science and nutrition.

[73]  D. Williamson,et al.  Origins of blood acetate in the rat. , 1977, Biochemical Journal.

[74]  N. Stamm,et al.  Regulation of gluconeogenesis and glycolysis: studies of mechanisms controlling enzyme activity. , 1967, Advances in enzyme regulation.